Skip to main content

Table 4 Type of anti-malarials used by source among individuals who reported having fever in last two weeks and who were treated for malaria (N = 875).

From: Self-reported fever, treatment actions and malaria infection prevalence in the northern states of Sudan

  Anti-malarial type
  AS+SP (n = 382) SP or Chloroquine (n = 122) Quinine (n = 39) Artemether (n = 296) Other(n = 36)
Overall 43.9 (39.6-48.2) 13.4 (10.6-16.2) 4.5 (2.8-6.1) 33.7 (30.0-37.4) 4.6(2.7-6.5)
By treatment source      
Government      
Hospital 29.0 (21.2-36.8) 20.3 (11.3-29.3) 50.2 (27.8-72.6) 28.4 (21.4-35.3) 21.4 (7.6-35.1)
Health centre 36.5 (27.3-45.7) 24.0 (14.7-33.2) 33.6 (11.1-56.1) 35.8 (29.2-42.4) 20.2 (4.7-35.8)
Basic health unit 10.5 (4.9-16.0) 14.6 (6.6-22.7) 5.4 (-0.0-11.1) 13.7 (7.6-19.7)  
Community Health Worker 7.0 (2.1-11.8) 5.8 (0.7-11.0) 7.2 (-0.2-14.6) 4.4 (1.7-7.2) 5.5 (-5.0-15.9)
Private      
Health facility/pharmacy/drug Store 14.6 (9.3-20.0) 20.0 (10.9-29.1) 2.1 (-1.9-6.2) 14.7 (10.3-19.1) 40.2 (18.3-62.1)
Shop 1.6 (0.3-28.6) 15.2 (7.3-23.2) 1.4 (-1.4-4.2) 1.1 (-0.6-2.9) 12.7 (-4.3-29.9)
Other 0.7 (-0.0-1.7)    1.8 (-0.0-3.8)  
  1. Proportions are weighted and cluster adjusted.
  2. 13 individuals took AL, 23 took unspecified anti-malarial drugs;